Wolfe JT - Search Results

1

De novo development of psoriatic plaques in patients receiving interferon alfa for treatment of erythrodermic cutaneous T-cell lymphoma.

Wolfe JT, Singh A, Lessin SR, Jaworsky C, Rook AH. Wolfe JT, et al. J Am Acad Dermatol. 1995 May;32(5 Pt 2):887-93. doi: 10.1016/0190-9622(95)91555-9. J Am Acad Dermatol. 1995. PMID: 7722051 Free article.

2

Treatment of cutaneous T-cell lymphoma with combined immunomodulatory therapy: a 14-year experience at a single institution.

Suchin KR, Cucchiara AJ, Gottleib SL, Wolfe JT, DeNardo BJ, Macey WH, Bromley PG, Vittorio CC, Rook AH. Suchin KR, et al. Among authors: wolfe jt. Arch Dermatol. 2002 Aug;138(8):1054-60. doi: 10.1001/archderm.138.8.1054. Arch Dermatol. 2002. PMID: 12164743

3

Eosinophilic fasciitis and eosinophilic cellulitis in a patient with abnormal circulating clonal T cells: increased production of interleukin 5 and inhibition by interferon alfa.

French LE, Shapiro M, Junkins-Hopkins JM, Wolfe JT, Rook AH. French LE, et al. Among authors: wolfe jt. J Am Acad Dermatol. 2003 Dec;49(6):1170-4. doi: 10.1016/s0190-9622(03)00447-x. J Am Acad Dermatol. 2003. PMID: 14639411

4

Large-cell transformation following detection of minimal residual disease in cutaneous T-cell lymphoma: molecular and in situ analysis of a single neoplastic T-cell clone expressing the identical T-cell receptor.

Wolfe JT, Chooback L, Finn DT, Jaworsky C, Rook AH, Lessin SR. Wolfe JT, et al. J Clin Oncol. 1995 Jul;13(7):1751-7. doi: 10.1200/JCO.1995.13.7.1751. J Clin Oncol. 1995. PMID: 7602365

5

Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection.

Wolfe JT, Lessin SR, Singh AH, Rook AH. Wolfe JT, et al. Artif Organs. 1994 Dec;18(12):888-97. doi: 10.1111/j.1525-1594.1994.tb03340.x. Artif Organs. 1994. PMID: 7887825 Review.

6

Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma.

Vowels BR, Lessin SR, Cassin M, Jaworsky C, Benoit B, Wolfe JT, Rook AH. Vowels BR, et al. Among authors: wolfe jt. J Invest Dermatol. 1994 Nov;103(5):669-73. doi: 10.1111/1523-1747.ep12398454. J Invest Dermatol. 1994. PMID: 7963654 Free article.

7

Role of extracorporeal photopheresis in the treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection.

Rook AH, Wolfe JT. Rook AH, et al. Among authors: wolfe jt. J Clin Apher. 1994;9(1):28-30. doi: 10.1002/jca.2920090108. J Clin Apher. 1994. PMID: 8195109 Review.

8

Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year experience at a single institution.

Gottlieb SL, Wolfe JT, Fox FE, DeNardo BJ, Macey WH, Bromley PG, Lessin SR, Rook AH. Gottlieb SL, et al. Among authors: wolfe jt. J Am Acad Dermatol. 1996 Dec;35(6):946-57. doi: 10.1016/s0190-9622(96)90119-x. J Am Acad Dermatol. 1996. PMID: 8959954 Free article.

9

Pathogenesis of cutaneous T-cell lymphoma: implications for the use of recombinant cytokines and photopheresis.

Rook AH, Gottlieb SL, Wolfe JT, Vowels BR, Sood SS, Niu Z, Lessin SR, Fox FE. Rook AH, et al. Among authors: wolfe jt. Clin Exp Immunol. 1997 Jan;107 Suppl 1:16-20. Clin Exp Immunol. 1997. PMID: 9020930 Free article. Review.

10

Cutaneous necrosis associated with recombinant interferon injection. Report of three cases with interferon beta-1b and review of the literature.

Weinberg JM, Wolfe JT, Sood S, Saruk M, Rook AH, Spiers EM. Weinberg JM, et al. Among authors: wolfe jt. Acta Derm Venereol. 1997 Mar;77(2):146-8. doi: 10.2340/00015555577146148. Acta Derm Venereol. 1997. PMID: 9111829 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

63 results

Search Page

Filters